Apricus Biosciences Shares Up 7.21% On High Volume; Apricus Spokesperson Tells Benzinga Co. Unaware Of Any Specific Catalyst Driving Today's Price Action, Highlights FDA PDUFA Date For Vitaros On Or Around Feb 17 As 'Next Known Catalyst'